Ferinject: Clinical Trials

68 trials of Ferinject, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed, 15 unknown, 6 terminated, 4 recruiting. 31 Phase 4, 20 Phase 3, 10 Not applicable, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 431Completed 14, Unknown 8, Terminated 4, Recruiting 3, Not yet recruiting 1, Withdrawn 1
Phase 320Completed 11, Unknown 3, Not yet recruiting 2, Terminated 2, Recruiting 1, Withdrawn 1
Not applicable10Completed 9, Unknown 1
Phase 25Completed 3, Terminated 1, Unknown 1

Follow Ferinject: new trials by email Literature Review of Ferinject trials Research Report on Ferinject

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia
Ferric Bepectate IV Injection, Ferric Carboxymaltose Injection [Ferinject], Ferric Carboxymaltose Injection [Injectafer®] - Iron Deficiency Anemia (IDA)
Phase 3Not yet recruitingAFT Pharmaceuticals, Ltd.13662026-12-012026-08-20
Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients
Ferric Carboxymaltose (FCM), Iron Sucrose injection - Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Not applicableCompletedSindh Institute of Urology and Transplantation1282025-04-012026-04-22
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
Iron Carboxymaltose, Dapagliflozin 10mg Tab, Placebo of Iron Carboxymaltose - Heart Failure, Systolic, Iron Deficiencies
Phase 3Not yet recruitingHospital de Clinicas de Porto Alegre992024-05-242024-06-03
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency
Phase 4UnknownUniversity of Padova2582024-01-152023-12-15
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
Venofer 200 MG Per 10 ML Injection, Ferinject - Anemia, Iron Deficiency, Pregnancy Anemia
Phase 4RecruitingWestern Galilee Hospital-Nahariya2002023-11-022026-09-11
The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures
Ferric carboxymaltose - Hip Fractures, Anemia
Phase 4CompletedIstanbul University2092023-10-102025-03-26
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
Ferinject, Diet therapy - Chronic Heart Failure, Iron Deficiency, Latent
Phase 4RecruitingTomsk National Research Medical Center of the Russian Academy of Sciences1002023-04-282026-06-24
Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
Ferinject, Ferrous Sulfate 200 MG - Iron Deficiency Anemia
Phase 4Not yet recruitingLiverpool Hope University1002023-01-012023-02-01
Hypoferritinemia Without Anemia Among Reproductive Age Females
Iron III Hydroxide Polymaltose Complex eq. to Elemental Iron, 100 mg, Ferric Carboxymaltose - Hypoferritenemia Without Anemia (HWA), Iron Deficiency Without Anemia)
Not applicableCompletedAkram Medical Complex3002022-10-102026-07-21
Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion
Ferinject, Sodium Chloride 0.9% Inj - Myocardial Infarction, Acute
Phase 4RecruitingWroclaw Medical University10002022-09-222025-07-30
Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)
Ferinject, oral iron - Celiac Disease
Phase 4TerminatedAssistance Publique - Hôpitaux de Paris12022-07-082026-07-09
Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.
Ferrous fumarate, MonoFer - Inflammatory Bowel Diseases
Not applicableUnknownLeiden University Medical Center1522022-06-022022-10-14
Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
Ferinject, Conservative management - Advanced Gastric Carcinoma
Phase 3RecruitingAsan Medical Center3302022-04-292026-04-03
.Patient Blood Management Program in Liver Transplantation
intravenous iron - Iron Deficiency Anemia
UnknownHospital Universitari de Bellvitge662022-03-232023-03-31
Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
Ferric carboxymaltose, Ferrous sulfate - Iron Deficiency Anemia of Pregnancy
Phase 3CompletedUniversity of Lagos, Nigeria10562021-08-092023-07-21
Iron and COVID-19 Vaccine Response
Ferinject - Iron Deficiency Anemia, Vaccine Response Impaired
Not applicableCompletedJomo Kenyatta University of Agriculture and Technology1212021-05-292025-09-04
Iron and Vaccine Response
Ferinject - Iron Deficiency Anemia, Vaccine Preventable Disease
Not applicableCompletedSwiss Federal Institute of Technology1212021-05-292021-09-14
Patient Blood Management In CARdiac sUrgical patientS
Ferric carboxymaltose, B vitamin, Folic acid - Anemia, Blood Loss Anemia
CompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS4792021-01-182025-08-14
Iron Deficiency as an Ignored Cause of Infertility
Ferric Carboxymaltose Injection, NaCl infusion - Iron Deficiency, Infertility
Phase 4UnknownDextra Fertility Clinic622020-08-172020-08-12
Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery
Ferinject, Normal saline - Hip Fractures
Phase 4UnknownSeoul National University Bundang Hospital2642020-07-302022-06-23

Showing 20 of 68. Sign in to see all of them.

Conditions studied

Anemia (25)  ·  Anemia, Iron-Deficiency (24)  ·  Iron Deficiencies (23)  ·  Heart Failure (7)  ·  Inflammatory Bowel Diseases (4)  ·  Colorectal Neoplasms (3)  ·  Heart Failure, Systolic (3)  ·  Colitis, Ulcerative (2)  ·  Crohn Disease (2)  ·  Fatigue (2)  ·  Hip Fractures (2)  ·  Lymphoproliferative Disorders (2)  ·  Postoperative Complications (2)  ·  Restless Legs Syndrome (2)  ·  Adenocarcinoma (1)

Sponsors

Vifor Pharma (6)  ·  University of Oxford (2)  ·  University of Zurich (2)  ·  AFT Pharmaceuticals, Ltd. (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Akram Medical Complex (1)  ·  American Regent, Inc. (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bayside Health (1)  ·  Biobizkaia Health Research Institute (1)  ·  Carol Davila University of Medicine and Pharmacy (1)  ·  Catharina Ziekenhuis Eindhoven (1)  ·  Dextra Fertility Clinic (1)

Countries

Germany (10)  ·  Netherlands (7)  ·  United Kingdom (7)  ·  Italy (5)  ·  South Korea (5)  ·  Austria (4)  ·  France (4)  ·  Poland (4)  ·  Romania (4)  ·  Spain (4)  ·  Sweden (4)  ·  Switzerland (4)  ·  Australia (3)  ·  Denmark (3)  ·  Greece (3)

Top investigators

Alla A. Garganeeva, M.D. (1)  ·  Ana Apodaka Diez, MD (1)  ·  Andreas Schneeweiss, MD, Prof. (1)  ·  Annabel H Nickol, MBBS PhD (1)  ·  Annabel MJ Blasi, MD, PhD (1)  ·  Annika Tulenheimo-Silfvast, M.D (1)  ·  Antonio Di Sabatino, MD (1)  ·  Austin G Acheson, MD FRCS (1)  ·  Bernard Favrat (1)  ·  Bjorn Backe, MD PhD (1)  ·  Bosede B Afolabi, DM(Notts) (1)  ·  Carolyn SP Lam, MBBS, MRCP (UK) (1)  ·  Christian Breymann (1)  ·  Christoph Gasche, Professor (1)

Results publications

PMID 31036337, PMID 10029607, PMID 10924610, PMID 11910485, PMID 17330243, PMID 1990875, PMID 20124051, PMID 20466657, PMID 22353604, PMID 23078888, PMID 2354408, PMID 23963731, PMID 24251969, PMID 24751822, PMID 24891437, PMID 26041028, PMID 26123286, PMID 27140401, PMID 27195774, PMID 27624208, PMID 27793204, PMID 28095881, PMID 28339831, PMID 29747838, PMID 30528802, PMID 30981629, PMID 31668348, PMID 31883356, PMID 32163106, PMID 32380660, PMID 32402684, PMID 32430412, PMID 32654663, PMID 32952616, PMID 33191846, PMID 33197395, PMID 33245866, PMID 33632377, PMID 34006287, PMID 34079413, PMID 34088733, PMID 34252375, PMID 34801353, PMID 3492188, PMID 35046429, PMID 35380718, PMID 36076211, PMID 36401886, PMID 36863386, PMID 37051919

NIH funding

2019 (2), 2008 (1), 2009 (1), 2014 (1), 2015 (1), 2016 (1), 2018 (1)